Betamox vet 150 mg/ml injektioneste, suspensio
Betamox vet 150 mg/ml injektioneste, suspensio
Authorised
- Amoxicillin trihydrate
Product identification
Medicine name:
Betamox vet 150 mg/ml injektioneste, suspensio
Active substance:
- Amoxicillin trihydrate
Target species:
-
Cattle
-
Sheep
-
Pig
-
Dog
-
Cat
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Amoxicillin trihydrate172.10/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle
-
Meat and offal39day
-
Milk108hour108 tuntia (4,5 vrk)
-
-
Sheep
-
Meat and offal29dayMaito: Valmistetta ei saa käyttää lampailla, joiden maitoa käytetään elintarvikkeena.
-
-
Pig
-
Meat and offal42day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01CA04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Finland
Available in:
-
Finland
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Informed consent (abridged application) - Council Directive 81/851/EEC
Marketing authorisation holder:
- Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Norbrook Laboratories Limited
- Norbrook Manufacturing Limited
Responsible authority:
- Finnish Medicines Agency
Authorisation number:
- 16405
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 18/05/2026
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 18/05/2026